1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 18 APRIL 2016

CNS Drug News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Demand For Vivitrol Will Rise As US Increases Efforts To Curb Opioid Epidemic
Industry Brief - Xadago Launched In Belgium To Treat Mid-To Late-Stage PD
Industry Brief - Aeolus Secures European/Japanese Patent Covering PD Compound AEOL 11114
Industry Trend Analysis - AstraZeneca And Eli Lilly Accelerate Alzheimer's Drug Development
Industry Trend Analysis - AD Acquisition Heralds Allergan's New Strategy To Drive Growth
Industry Brief - FDA ODD For ANAVEX 3-71 To Treat Frontotemporal Dementia
Industry Brief - Aricept Approved In Philippines To Treat Dementia With Lewy Bodies
Industry Trend Analysis - Dr Reddy's Sees New Horizon In XP23829
Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Brief - Lupin Launches Zolpidem Sublingual Tablets
Industry Brief - Benjorna Yields Positive Outcomes In Phase III ADHD Trials
Industry Brief - Shire Seeks FDA Approval For New Formulation Of Vyvanse
Industry Brief - FDA Advises To Amend Posimir Phase III PERSIST Trial Programme
Industry Trend Analysis - FTC Intervention Threatens Generic Marketing Exclusivity Period Value
Industry Trend Analysis - Remoxy Will Struggle In Changing Opioid Market
Industry Brief - Promius Pharma Launches Sumatriptan Product
Industry Brief - Enrolment Target Reached In CAM2038 Phase III Trials To Treat Opioid Dependence
Industry Trend Analysis - Expanding In Niche Indications Will Help Boost Epidiolex Success
Industry Brief - FDA Grants Ganaxolone ODD Status
Industry Brief - MedDay Secures Funding To Advance MD1003 Development In MS
Industry Brief - Martindale Pharma Enters Distribution Deal In Ireland
Industry Brief - CNS Conferences - July 2016

Table Of Contents

CNS Drug News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.